{
    "2021-05-07": [
        [
            {
                "time": "2021-05-07",
                "original_text": "Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2021",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "board members",
                        "executives",
                        "trading"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-07",
                "original_text": "Novo Nordisk A/S â€“ Share repurchase programme",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "share repurchase",
                        "programme"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-07",
                "original_text": "Novo Nordisk A/S purchases B shares worth DKK 2,586 million from Novo Holdings A/S under the 2021 share repurchase programme",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "B shares",
                        "DKK 2,586 million",
                        "Novo Holdings",
                        "repurchase"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-07",
                "original_text": "PFE vs. NVO: Which Stock Should Value Investors Buy Now?",
                "features": {
                    "keywords": [
                        "PFE",
                        "NVO",
                        "value investors",
                        "buy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}